Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondroplasia
Clinical trial NCT05116046 · TERMINATED
Trial details
- NCT number
- NCT05116046
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-24
- Primary completion
- 2022-12-16
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.